Welcome to LookChem.com Sign In|Join Free

CAS

  • or

73544-70-4

Post Buying Request

73544-70-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

73544-70-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 73544-70-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,5,4 and 4 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 73544-70:
(7*7)+(6*3)+(5*5)+(4*4)+(3*4)+(2*7)+(1*0)=134
134 % 10 = 4
So 73544-70-4 is a valid CAS Registry Number.

73544-70-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 1,3-benzothiazol-2-ylmethanethiol

1.2 Other means of identification

Product number -
Other names 2-Benzothiazolemethanethiol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:73544-70-4 SDS

73544-70-4Downstream Products

73544-70-4Relevant articles and documents

Preparation methods of 2-[(2-benzothiazolylmethyl)thio]-6-ethoxybenzothiazole and intermediates thereof

-

Page/Page column 7-14, (2018/12/02)

The invention provides a preparation method of 2-[(2-benzothiazolylmethyl)thio]-6-ethoxybenzothiazole. The method includes reacting a compound (II) and a compound (III) in a solvent under an alkalinecondition with or without a catalyst to obtain a compound (I) that is the 2-[(2-benzothiazolylmethyl)thio]-6-ethoxybenzothiazole. The invention further provides a preparation method of the compound (II), including reacting a compound (IV) with a nitrosation agent and a copper agent in order in a solvent. The invention further provides a preparation method of the compound (III), including reactinga compound (V) with a sulfurizing agent in a solvent to obtain the compound (III). According to the methods, raw materials are cheap and easily available or easy to prepare, reaction conditions are mild, and selectivity and yields are high. The intermediates and a product are purified through crystallization instead of column chromatography and the methods are suitable for industrialization.

Substituted organosulfur compounds and methods of using thereof

-

Page/Page column 9, (2008/06/13)

The present invention provides substituted di-, tri-, tetra- and penta-sulfide compounds and compositions, and methods of using the same for the treatment and/or prevention of a cell proliferative disorder. The present invention also provides methods for preparing trisulfide compounds and compositions.

Synthesis and Biological Activity of trans-(+/-)-N-Methyl-2-(3-pirydyl)-2-tetrahydrothiopyrancarbothioamide 1-Oxide (RP 49356) and Analogues: A New Class of Potassium Channel Opener

Brown, Thomas J.,Chapman, Robert F.,Cook, David C.,Hart, Terance W.,McLay, Iain M.,et al.

, p. 3613 - 3624 (2007/10/02)

The synthesis and biological activity of trans-(+/-)-N-methyl-2-(3-pyridyl)-2-tetrahydrothiopyrancarbothioamide 1-oxide (8a, RP 49356) and analoques is reported.These compounds constitute a new structural class of K+-channel opener.The effects of changes in the pyridyl group, thioamide, and thiane ring on in vitro K+-channel opening activity are discussed.A 3-pyridyl or 3-quinolyl group, a small N-alkyl thioamide function, and a thiane oxide ring, in which the sulfoxide is in a trans relationship to thioamide, are preferred for activity.Selected compounds were tested intravenously in the normotensive anaesthetized rat for hypotensive effects, and the activities reflect their in vitro K+-channel opening activity.This led to further evaluation of compound 8a and the selection of the (-)-enantiomer 8b (RP 52891) for development as an antihypertensive and antianginal agent.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 73544-70-4